tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CLNN Stock Latest News

Promising Potential of Clene’s CNM-Au8 in MS: Analyst Recommends Buy Rating
RatingsPromising Potential of Clene’s CNM-Au8 in MS: Analyst Recommends Buy Rating
1d ago
CLNN
Clene Showcases CNM-Au8® Advancements at Neurology Session
PremiumCompany Announcements
Clene Showcases CNM-Au8® Advancements at Neurology Session
1d ago
8K
CLNN
Clene announces evidence of remyelination, neuronal repair with CNM-Au8
PremiumThe Fly
Clene announces evidence of remyelination, neuronal repair with CNM-Au8
1d ago
CLNN
Clene’s Strategic Advancements and Financial Position Reinforce Buy Rating for CNM-Au8’s Promising Future
PremiumRatings
Clene’s Strategic Advancements and Financial Position Reinforce Buy Rating for CNM-Au8’s Promising Future
13d ago
CLNN
Clene files $160M mixed securities shelf
PremiumThe Fly
Clene files $160M mixed securities shelf
15d ago
CLNN
Clene Inc. Reports 2024 Financial Results and Strategic Plans
PremiumCompany AnnouncementsClene Inc. Reports 2024 Financial Results and Strategic Plans
16d ago
CLNN
Clene’s Strategic Advancements and Promising Data Drive Buy Rating for ALS Treatment
Premium
Ratings
Clene’s Strategic Advancements and Promising Data Drive Buy Rating for ALS Treatment
16d ago
CLNN
Clene reports FY24 EPS ($5.67), consensus ($4.48)
Premium
The Fly
Clene reports FY24 EPS ($5.67), consensus ($4.48)
16d ago
CLNN
Clene sees cash runway into 2Q25
PremiumThe Fly
Clene sees cash runway into 2Q25
16d ago
CLNN
Promising Potential of Clene’s CNM-Au8 for ALS Drives Buy Rating
PremiumRatings
Promising Potential of Clene’s CNM-Au8 for ALS Drives Buy Rating
28d ago
CLNN
Clene announces evidence from post-hoc analysis of HEALY ALS platform trial
PremiumThe Fly
Clene announces evidence from post-hoc analysis of HEALY ALS platform trial
28d ago
CLNN
Strategic Advancements and Regulatory Progress Bolster Clene’s ALS Treatment Outlook
PremiumRatings
Strategic Advancements and Regulatory Progress Bolster Clene’s ALS Treatment Outlook
1M ago
CLNN
Clene, ASPT Research enter agreement to utilize NfL database for CNM-Au8
PremiumThe FlyClene, ASPT Research enter agreement to utilize NfL database for CNM-Au8
1M ago
CLNN
Clene files to sell 1.15M shares of common stock for holders
Premium
The Fly
Clene files to sell 1.15M shares of common stock for holders
2M ago
CLNN
Five new option listings and option delistings on January 21st
Premium
The Fly
Five new option listings and option delistings on January 21st
3M ago
SQ
ADN
Clene Secures $10M Debt Facility to Enhance Position
PremiumCompany Announcements
Clene Secures $10M Debt Facility to Enhance Position
4M ago
8K
CLNN
Clene secures debt facility to pay off existing senior loan
PremiumThe Fly
Clene secures debt facility to pay off existing senior loan
4M ago
CLNN
Clene Gains FDA Support for ALS Treatment Approval
PremiumCompany Announcements
Clene Gains FDA Support for ALS Treatment Approval
4M ago
8K
CLNN
Clene receives written guidance from DN1 of U.S. FDA on pathway for CNM-Au8
PremiumThe Fly
Clene receives written guidance from DN1 of U.S. FDA on pathway for CNM-Au8
4M ago
CLNN
Clene price target lowered to $84 from $90 at Benchmark
PremiumThe FlyClene price target lowered to $84 from $90 at Benchmark
5M ago
CLNN
Clene price target lowered to $83 from $86 at Canaccord
Premium
The Fly
Clene price target lowered to $83 from $86 at Canaccord
5M ago
CLNN
Clene Announces Q3 2024 Results and ALS Drug Progress
Premium
Company Announcements
Clene Announces Q3 2024 Results and ALS Drug Progress
5M ago
8K
CLNN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >